You are currently not logged in
For time-critical workflows in the biopharmaceutical industry - Transform immunoassay performance

Immunoassays from discovery to the clinic

Gyros immunoassay platform in action at:

Quotient Bioresearch

RecipharmCobra Biologics

Rentschler Biotechnologie

ProBioGen

MPI Research

Novo Nordisk

Pfizer

Morphotek

Roche

QPS

Thrombogenics

York Bioanalytical Solutions

Covance

Syrinx Bioanalytics

Radix BioSolutions

Lonza

Rudbeck Laboratory

NovImmune

Millipore

GE Healthcare

GlaxoSmithKline

ICON

Worldwide Clinical Trials

Ablynx

Bayer Schering Pharma

Biogen Idec

Bristol-Myers Squibb

Huntingdon Life Sciences

PhaseBio Pharmaceuticals

National Research Centre for the Working Environment (AMI)

National Veterinary Institute

Novartis

MerckSerono

Amgen

MedImmune

Merck

AstraZeneca

Helps us to provide a better service to our clients

Dr. M. Kania, Rentschler Biotechnologie

Gyros news

Uppsala, Sweden, 7 December 2011

Gyros expands commercial reach in Asia

Uppsala, Sweden, 20 October 2011

Gyros announces changes to its management team

Uppsala, Sweden, 11 October 2011

Gyros introduces new application to monitor anti-drug antibodies during development of biotherapeutics

In focus

Upcoming events

27 February - 2 March 2012 - San Diego, California

Biopharmaceutical Development & Production Week

9-10 March 2012 - Holiday Inn Munich City Centre,Germany

Immunogenicity for Biologics

11-15 March 2012 - San Francisco, California

Society of Toxicology 2012

{h_blk_flyout_menuitem_1}

Gyros immunoassay platform

See how Gyrolab products and nanoliter-scale technology transform performance and productivity

Develop and run immunoassays at nanoliter scale:

Ready to use on Gyrolab xP workstation

Designed for use with Gyrolab CDs

Login
E-mail:
Password:
Remember me

If you do not have a Gyros website account yet:
request one here.

If you forgot your password:
request a new one.